DRUG TREATMENT BOOST

Work on a new COVID-19 drug by a Tulane researcher is getting fast-tracked. Dr. Jay Kolls, a professor of medicine and pediatrics, the John W. Deming Endowed Chair in Internal Medicine, and director of the Center for Translational Research in Infection and Inflammation, has received a $100,000 Fast Grant for his research to create a drug that prevents the COVID-19 virus from entering healthy cells.

Horizontal thumbnail